Skip to main content
Log in

Effects of a highly selective plasma kallikrein inhibitor on collagen-induced arthritis in mice

  • Inflammation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

A study was conducted to evaluate the effects of a new, highly selective plasma kallikrein inhibitor, PKSI-527, on collagen-induced arthritis (CIA) in mice. PKSI-527 or indomethacin was administered daily intraperitoneally from day 20 postimmunization. Clinical evaluation was performed, and two of the components of the kallikrein-kinin system, high-molecular-weight (HMW) kininogen and plasma prekallikrein, were assyed. PKSI-527, as well as indomethacin, reduced the severity of arthritis significantly. PKSI-527, but not indomethacin, restored consumed components of the kallikrein-kinin system. These results suggest that PKSI-527 suppresses CIA by modifying the kallikrein-kinin system and PKSI-527 as a synthetic plasma kallikrein inhibitor would be a valuable tool to study the mechanism of inflammation of arthritic diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. D. Regoli,Kinins. Br. Med. Bull.43, 270–284 (1987).

    Google Scholar 

  2. R. Holmdahl, M. E. Andersson, T. J. Goldschmidt, L. Jansson, M. Karlsson, V. Malmström and J. Mo,Collagen induced arthritis as an experimental model for rheumatoid arthritis. APMIS97, 575–584 (1989).

    Google Scholar 

  3. J. S. Courtenay, M. J. Dallman, A. D. Dayan, A. Martin and B. Mosedale,Immunization against heterologous type II collagen induces arthritis in mice. Nature283, 666–668 (1980).

    Google Scholar 

  4. J. M. Stuart, W. C. Watson and A. H. Kang,Collagen autoimmunity and arthritis. FASEB J.2, 2950–2956 (1988).

    Google Scholar 

  5. P. H. Wooley,Collagen-induced arthritis in the mouse. Methods Enzymol.162, 361–373 (1988).

    Google Scholar 

  6. K. Takagishi, N. Kaibara, T. Hotokebuchi, C. Arita, M. Morinaga and K. arai,Effects of cyclosporin on collagen induced arthritis in mice. Ann. Rheum. Dis.45, 339–344 (1986).

    Google Scholar 

  7. P. H. Wooley, J. D. Whalen, J. L. Zimmerman and T. M. Champion,The effect of etodolac on type II collageninduced arthritis in mice. Agents and Actions21, 244–246 (1987).

    Google Scholar 

  8. J. Björk and S. Kleinau,Paradoxical effects of LS-2616 (Linomide) treatment in the type II collagen induced arthritis model in mice. Agents and Actions27, 319–321 (1989).

    Google Scholar 

  9. D. F. Carmichael, G. P. Stricklin and J. M. Stuart,Systemic administration of TIMP in the treatment of collagen-induced arthritis in mice. Agents and Actions27, 378–379 (1989).

    Google Scholar 

  10. K. Takagishi, M. Yamamoto, A. Nishimura, G. Yamasaki, N. Kanazawa, T. Hotokebuchi and N. Kaibara,Effects of FK-506 on collagen arthritis in mice. Transplant. Proc.21, 1053–1055 (1989).

    Google Scholar 

  11. J. A. Wolos, D. E. Logan and T. L. Bowlin,Methylacetylenic putrescine (MAP), an inhibitor of polyamine biosynthesis, prevents the development of collageninduced arthritis. Cell. Immunol.125, 498–507 (1990).

    Google Scholar 

  12. H. Nakajima, H. Takamori, Y. Hiyama and W. Tsukada,The effect of treatment with inerferon-gamma on type II collagen-induced arthritis. Clin. Exp. Immunol.81, 441–445 (1990).

    Google Scholar 

  13. K. Takagishi, M. Yamamoto, K. Maeda, A. Nishimura, K. Yonemoto, T. Hotokebuchi and N. Kaibara,Effects of deoxyspergualin on collagen arthritis in mice. Clin. Immunol. Immunopathol.56, 81–87 (1990).

    Google Scholar 

  14. A. Ueno, S. Oh-ishi, T. Kitagawa and M. Katori,Enzyme immunoassay of bradykinin using β-D-galactosidase as a labeling enzyme. Biochem. Pharmacol.30, 1659–1664 (1981).

    Google Scholar 

  15. K. Wanaka, S. Okamoto, M. Bohgaki, A. Hijikata-Okunomiya, T. Naito and Y. Okada,Effect of a highly selective plasma-kallikrein synthetic inhibitor on contact activation relating to kinin generation, coagulation and fibrinolysis. Thromb. Res.57, 889–895 (1990).

    Google Scholar 

  16. K. Ikeda, K. Tanaka and M. Katori,Potentiation of bradykinin-induced vascular permeability increase by prostaglandin E 2 and arachidonic acid in rabbit skin. Prostaglandins10, 747–758 (1975).

    Google Scholar 

  17. G. S. Basran, J. Morley, W. Paul and M. Turner-Warwick,Evidence in man of synergistic interaction between putative mediators of acute inflammation and asthma. Lancet1, 935–937 (1982).

    Google Scholar 

  18. D. Regoli,Neurohumoral regulation of precapillary vessels: The kallikrein-kinin system. J. Cardiovasc. Pharmacol.6 (Suppl 2). 401–412 (1984).

    Google Scholar 

  19. F. Guzman, C. Braun and R. K. S. Lim,Visceral pain and the pseudoaffective response to intra-arterial injections of bradykinin and other algesic agents. Arch. Int. Pharmacodyn.136, 353–384 (1962).

    Google Scholar 

  20. L. Stoppini, F. Barja, R. Mathison and J. Baertschi,Spinal substance P transmits bradykinin but not osmotic stimuli from hepatic portal vein to hypothalamus in rat. Neuroscience11, 903–912 (1984).

    Google Scholar 

  21. K. M. Hargreaves, E. S. Troullos, R. A. Dionne, E. A. Schmidt, S. C. Schafer and J. L. Joris,Bradykinin is increased during acute and chronic inflammation: Therapeutic implications. Clin. Pharmacol. Ther.44, 613–621 (1988).

    Google Scholar 

  22. H. Fritz and G. Wunderer,Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Drug Res.33, 479–494 (1983).

    Google Scholar 

  23. T. Aoyama, Y. Ino, M. Ozeki, M. Oda, T. Sato, Y. Koshiyama, S. Suzuki and M. Fujita,Pharmacological studies of FUT-175, nafamstat mesilate: I. Inhibition of protease activity in in vitro and in vivo experiments. Jap. J. Pharmacol.35, 203–227 (1984).

    Google Scholar 

  24. J. A. Salmon and G. A. Higgs,Prostaglandins and leukotrienes as inflammatory mediators. Br. Med. Bull.43, 285–296 (1987).

    Google Scholar 

  25. K. Phadke, R. L. Fouts, J. E. Parrish and L. D. Butler,Evaluation of the effects of various anti-arthritic drugs on type II collagen-induced mouse arthritis model. Immunopharmacology10, 51–60 (1985).

    Google Scholar 

  26. C. Rordorf, A. Pataki, V. Nogues, F. Schlager, U. Feige and M. Glatt,Arthritis in MRL/lpr mice and in collagen II sensitized DBA-1 mice and their use in pharmacology. Int. J. Tissue. React.9, 341–347 (1987).

    Google Scholar 

  27. W. Paska, K. J. McDonald and M. Croft,Studies on type II collagen induced arthritis in mice. Agents and Actions18, 413–420 (1986).

    Google Scholar 

  28. D. E. Griswold, L. M. Hillegass, P. C. Meunier, M. J. DiMartino and N. Hanna,Effect of inhibitors of eicosanoid metabolism in murine collagen-induced arthritis. Arth. Rheum.31, 1406–1412 (1988).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fujimori, Y., Nakamura, T., Shimizu, K. et al. Effects of a highly selective plasma kallikrein inhibitor on collagen-induced arthritis in mice. Agents and Actions 39, 42–48 (1993). https://doi.org/10.1007/BF01975713

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01975713

Keywords

Navigation